Despite the Trump administration's tariff threats and pressure to move more manufacturing to the U.S., the push to raise ...

With AI expected to play a significant role in drug approvals, how can companies build data sets that are ready for AI?

Merck has announced the acquisition of SpringWorks, which is expected to close this year, for an enterprise value of EUR 3 billion. While the deal appears expensive at an 18 times price/sales multiple ...

Shares of Hikal hit a 52-week low of ₹281.90, falling 8 per cent on the BSE in Thursday's intra-day trade after the pharma company posted a net loss of ₹22.4 crore in Q1FY26.

Swiss pharmaceutical giant Novartis is exploring a potential acquisition of U.S. biotech firm Avidity Biosciences, according ...

The global trading system is adjusting to the tariffs levied by the United States: for most goods they look likely to settle ...

Pfizer is the closest company to producing a Lyme disease vaccine. Experts are concerned that vaccine skepticism could stand in its way.

The 2025 Clinical Trial Supply West Coast conference will gather experts to discuss US trial operations in a shifting tariff ...